Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L C Cork

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
Clinical Neuropharmacology|January 1, 1991
Amyloid-related proteins and nerve growth factor in Alzheimer's disease and animal modelsD L Price, V E Koliatsos, S S Sisodia, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1991
Amyloid precursor protein in aged nonhuman primatesL J Martin, S S Sisodia, E H Koo, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Alzheimer's disease and Down's syndromeD L Price, P J Whitehouse, R G Struble, et al.
Progress in Brain Research|January 1, 1990
Neuronal responses to injury and aging: lessons from animal modelsD L Price, E H Koo, S S Sisodia, et al.
Advances in Neurology|January 1, 1990
Behavioral, cellular, and molecular biological studies of aged nonhuman primatesD L Price, E H Koo, M V Wagster, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Brain Research. Brain Research Reviews|January 11, 1991
Regulation and genetic control of brain amyloid. FESN Study GroupD C Gajdusek, K Beyreuther, P Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogeneF Propst, M P Rosenberg, L C Cork, et al.
Science (New York, N.Y.)|May 2, 1997
The costs of animal research: origins and optionsL C Cork, T B Clarkson, R O Jacoby, et al.
Neurobiology of Aging|January 8, 1999
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesisW S Griffin, J G Sheng, J E McKenzie, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
Clinical Neuropharmacology|January 1, 1991
Amyloid-related proteins and nerve growth factor in Alzheimer's disease and animal modelsD L Price, V E Koliatsos, S S Sisodia, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 15, 1991
Amyloid precursor protein in aged nonhuman primatesL J Martin, S S Sisodia, E H Koo, et al.
Annals of the New York Academy of Sciences|January 1, 1982
Alzheimer's disease and Down's syndromeD L Price, P J Whitehouse, R G Struble, et al.
Progress in Brain Research|January 1, 1990
Neuronal responses to injury and aging: lessons from animal modelsD L Price, E H Koo, S S Sisodia, et al.
Advances in Neurology|January 1, 1990
Behavioral, cellular, and molecular biological studies of aged nonhuman primatesD L Price, E H Koo, M V Wagster, et al.
The Journal of Experimental Medicine|February 1, 1994
The third component of complement protects against Escherichia coli endotoxin-induced shock and multiple organ failureZ M Quezado, W D Hoffman, J A Winkelstein, et al.
Brain Research. Brain Research Reviews|January 11, 1991
Regulation and genetic control of brain amyloid. FESN Study GroupD C Gajdusek, K Beyreuther, P Brown, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogeneF Propst, M P Rosenberg, L C Cork, et al.
Science (New York, N.Y.)|May 2, 1997
The costs of animal research: origins and optionsL C Cork, T B Clarkson, R O Jacoby, et al.
Neurobiology of Aging|January 8, 1999
Life-long overexpression of S100beta in Down's syndrome: implications for Alzheimer pathogenesisW S Griffin, J G Sheng, J E McKenzie, et al.
Pageof 13